

[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
Jay Olson Maintained (ACAD) at Hold with Increased Target to $20 on, Mar 1st, 2023
Jay Olson of Oppenheimer, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Increased Target from $17 to $20 on, Mar 1st, 2023.
Jay has made no other calls on ACAD in the last 4 months.
There are 10 other peers that have a rating on ACAD. Out of the 10 peers that are also analyzing ACAD, 6 agree with Jay's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jason West of "JMP Securities" Maintained at Hold with Decreased Target to $22 on, Tuesday, February 28th, 2023
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Increased Target to $19 on, Tuesday, February 28th, 2023
- Neena Bitritto-Garg of "Citigroup" Maintained at Hold and Held Target at $19 on, Tuesday, February 28th, 2023
- Uy Ear of "Mizuho" Maintained at Hold with Increased Target to $19 on, Tuesday, February 28th, 2023
- Tessa Romero of "JP Morgan" Maintained at Hold with Decreased Target to $17 on, Monday, November 14th, 2022
- Esther Hong of "Loop Capital" Initiated at Hold and Held Target at $17 on, Tuesday, November 1st, 2022
These are the ratings of the 4 analyists that currently disagree with Jay
- Gregory Renza of "RBC Capital" Maintained at Buy with Increased Target to $27 on, Tuesday, February 28th, 2023
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $25 on, Tuesday, February 28th, 2023
- Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $22 on, Tuesday, January 3rd, 2023
- Salveen Richter of "Goldman Sachs" Downgraded from Hold to Strong Sell and Decreased Target to $12 on, Friday, November 4th, 2022
Contributing Sources